Skip to content

Milestone Scientific Advances CompuFlo® Acceptance in Clinical Settings

Milestone Scientific, Inc. has reported growing clinical adoption and acceptance of its CompuFlo® Epidural System, bolstered by a recent study from the University of Texas Medical Branch. The research indicates that the CompuFlo system significantly lowers complication rates during spinal cord stimulator procedures compared to traditional methods. CompuFlo technology enhances procedural precision and safety through real-time pressure sensing, contributing to a 91% reduction in composite complications in the studied procedures, and is being utilized in various medical applications worldwide.

ROSELAND, N.J., May 27, 2026 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensing™ (DPS) technology, today highlighted the continued growth in clinical adoption and physician acceptance of its CompuFlo® Epidural System following the publication of new peer-reviewed research from the University of Texas Medical Branch (UTMB).